Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
暂无分享,去创建一个
M. Hochberg | D. Furst | M. Hannan | E. Tindall | K. Saag | N. Lane | L. Caplan | N. Patkar | J. Curtis | J. Grossman | M. Greenwald | C. Deal | M. McMahon | D. Lovell | M. Prashker | E. Volkmann | V. Ranganath | S. Lindsey | Weiling Chen | Rancho Mirage | R. Gordon | Marc C. Hochberg | Jennifer Grossman | Rebecca Gordon | Chad Deal | Jeffrey R. Curtis | Daniel E. Furst | Maureen McMahon | Elizabeth Volkmann | Mark J. Prashker | Maria Greenwald | Marian T. Hannan | Nancy E Lane | Stephen M. Lindsey | Daniel J. Lovell | Elizabeth A. Tindall | Daniel J. Lovell | Marian T. Hannan | Nancy E. Lane | N. E. Lane
[1] Keith C. Norris,et al. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] J. Ringe,et al. Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study , 2003, Osteoporosis International.
[3] J. Ringe,et al. Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis. , 2003, Rheumatology.
[4] V. Naganathan,et al. Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis: A Comparison of Calcitriol, Vitamin D Plus Calcium, and Alendronate Plus Calcium , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] Kunio Nakamura,et al. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup. , 2003, The Journal of rheumatology.
[6] J. Katz,et al. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. , 2002, Arthritis and rheumatism.
[7] A. Thapar,et al. Quality assessment for three common conditions in primary care: validity and reliability of review criteria developed by expert panels for angina, asthma and type 2 diabetes , 2002, Quality & safety in health care.
[8] L. Leape,et al. Sensitivity and specificity of the RAND/UCLA Appropriateness Method to identify the overuse and underuse of coronary revascularization and hysterectomy. , 2001, Journal of clinical epidemiology.
[9] H. Ucan,et al. Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids , 2001, Rheumatology International.
[10] Jacques P. Brown,et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. , 2001, Arthritis and rheumatism.
[11] C. Cooper,et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. , 2000, Rheumatology.
[12] Jacques P. Brown,et al. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss. , 2000, The Journal of rheumatology.
[13] D. Reid,et al. Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy , 2000, Calcified Tissue International.
[14] Y. Jinnouchi. Efficacy of intermittent etidronate therapy for corticosteroid-induced osteoporosis in patients with diffuse connective tissue disease. , 2000, The Kurume medical journal.
[15] I. Lambrinoudaki,et al. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. , 2000, The Journal of rheumatology.
[16] M. Suarez‐Almazor,et al. Calcium and vitamin D for corticosteroid-induced osteoporosis. , 1998, The Cochrane database of systematic reviews.
[17] M. Suarez‐Almazor,et al. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. , 2000, The Cochrane database of systematic reviews.
[18] D. Reid,et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] P. Lakatos,et al. Prevention of corticosteroid-induced osteoporosis by alfacalcidol , 2000, Zeitschrift für Rheumatologie.
[20] T. Chan,et al. Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy. , 1999, Rheumatology.
[21] S. Wallach,et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. , 1999, Arthritis and rheumatism.
[22] D. Felson,et al. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. , 1999, Arthritis and rheumatism.
[23] M. Suarez‐Almazor,et al. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis. , 1999, The Journal of rheumatology.
[24] C. Roux,et al. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study. , 1999, Revue du rhumatisme.
[25] M. Cawley,et al. The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate. , 1999, Scandinavian journal of rheumatology.
[26] P. Geusens,et al. Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study , 1998, Annals of the rheumatic diseases.
[27] H. Genant,et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. , 1998, The Journal of clinical investigation.
[28] Jacques P. Brown,et al. Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .
[29] J P Kahan,et al. The reproducibility of a method to identify the overuse and underuse of medical procedures. , 1998, The New England journal of medicine.
[30] N. Lane,et al. The science and therapy of glucocorticoid-induced bone loss. , 1998, Endocrinology and metabolism clinics of North America.
[31] C. Moniz,et al. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment , 1998, Thorax.
[32] C. Roux,et al. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. , 1998, The Journal of clinical endocrinology and metabolism.
[33] P. Rottoli,et al. Prevention of Corticosteroid-Induced Osteoporosis with Alendronate in Sarcoid Patients , 1997, Calcified Tissue International.
[34] Mooré Dj,et al. Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy. , 1997 .
[35] R. Lindsay,et al. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis , 1997, The Lancet.
[36] Jacques P. Brown,et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. , 1997, The New England journal of medicine.
[37] W. Hop,et al. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. , 1997, Journal of hepatology.
[38] E. Themeles,et al. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. , 1997, British journal of rheumatology.
[39] W. Lems,et al. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis? , 1996, Annals of the rheumatic diseases.
[40] E. Leib,et al. Calcium and Vitamin D3 Supplementation Prevents Bone Loss in the Spine Secondary to Low-Dose Corticosteroids in Patients with Rheumatoid Arthritis , 1996, Annals of Internal Medicine.
[41] M. Kataja,et al. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy? , 1996, The Journal of rheumatology.
[42] C. Bernstein,et al. A randomized, placebo‐controlled trial of calcium supplementation for decreased bone density in corticosteroid‐using patients with inflammatory bowel disease: a pilot study , 1996, Alimentary pharmacology & therapeutics.
[43] M. Pringle,et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study , 1996, BMJ.
[44] G. Rodan,et al. Bisphosphonates: mechanisms of action , 1998, Endocrine reviews.
[45] S. Majumdar,et al. Noninvasive assessment of bone mineral and structure: State of the art , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] P. Tugwell,et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. , 1996, The Journal of rheumatology.
[47] H K Genant,et al. Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. , 1996, Seminars in arthritis and rheumatism.
[48] W. Bremner,et al. Androgens in men--uses and abuses. , 1996, The New England journal of medicine.
[49] Gulko Ps,et al. Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment. , 1996 .
[50] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[51] E. Barrett-Connor,et al. Inhaled and oral corticosteroids: their effects on bone mineral density in older adults. , 1995, American journal of public health.
[52] N. Hanania,et al. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. , 1995, The Journal of allergy and clinical immunology.
[53] R. Heaney. Optimal calcium intake. , 1995, JAMA.
[54] H. Mulder,et al. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. , 1995, The American journal of medicine.
[55] J. Dequeker,et al. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention. , 1995, The Journal of rheumatology.
[56] P. Vacek,et al. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. , 1995, The Journal of rheumatology.
[57] R. Eastell. Management of corticosteroid‐induced osteoporosis , 1995 .
[58] S. Barbagallo,et al. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. , 1995, The American journal of medicine.
[59] M. Hochberg,et al. Prevention and management of glucocorticoid-induced osteoporosis. , 1995, Bulletin on the rheumatic diseases.
[60] G. Gronowicz,et al. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels. , 1995, Endocrinology.
[61] D. Reid,et al. Steroid induced osteoporosis: an opportunity for prevention? , 1995, Annals of the rheumatic diseases.
[62] J. Eisman,et al. Thiazide diuretics and fractures: Can meta‐analysis help? , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[63] C. Cooper,et al. Rheumatoid arthritis, corticosteroid therapy and hip fracture. , 1995, Annals of the rheumatic diseases.
[64] C. Picado,et al. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study. , 1994, Thorax.
[65] T. Spector,et al. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. , 1994, Arthritis and rheumatism.
[66] C. Goldsmith,et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. , 1994, The Journal of rheumatology.
[67] G. Boyd. Effect of inhaled corticosteroids on bone. , 1994, Respiratory medicine.
[68] S L Hui,et al. Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity. , 1994, The Journal of pediatrics.
[69] C. Libanati,et al. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. , 1994, Rheumatic diseases clinics of North America.
[70] E. Barrett-Connor,et al. Thiazides and bone mineral density in elderly men and women. , 1994, American journal of epidemiology.
[71] H. Mulder,et al. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. , 1994, British journal of rheumatology.
[72] C. Lindsley,et al. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. , 1994, The Journal of rheumatology.
[73] D. Furst,et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. , 1994, The American journal of medicine.
[74] J. C. Joseph. Corticosteroid-induced osteoporosis. , 1994, American journal of hospital pharmacy.
[75] F. Wolfe,et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. , 1993, The Journal of rheumatology.
[76] S. Ljunghall,et al. Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts , 1993, Bioscience reports.
[77] G. Benker,et al. Glucocorticoid‐induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases , 1993, Journal of internal medicine.
[78] M. Nevitt,et al. Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[79] J. Eisman,et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. , 1993, The New England journal of medicine.
[80] J. Adachi,et al. Corticosteroid-induced osteoporosis. , 1993, Seminars in arthritis and rheumatism.
[81] S. Cummings,et al. Effects of Thiazide Diuretic Therapy on Bone Mass, Fractures, and Falls , 1993, Annals of Internal Medicine.
[82] M. Ward. Inhaled corticosteroids--effect on bone? , 1993, Respiratory medicine.
[83] D. Galuska,et al. Epidemiology of bone mass in premenopausal women. , 1993, Epidemiologic reviews.
[84] C. Libanati,et al. Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. , 1992, Chest.
[85] R. Robinson,et al. Estrogen and progesterone replacement therapy reduces glucocorticoid‐induced bone loss , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[86] S. Cummings,et al. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. , 1992, Annals of internal medicine.
[87] D. Allen,et al. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children. , 1992, Pediatrics.
[88] R. Kreipe. Bones of today, bones of tomorrow. , 1992, American journal of diseases of children.
[89] S. Silverman,et al. Glucocorticoid-induced osteoporosis: a cross-sectional study , 1991, Steroids.
[90] E. Canalis,et al. Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone , 1991, Molecular and cellular biology.
[91] J. Fries,et al. Predictors of fractures in early rheumatoid arthritis. , 1991, The Journal of rheumatology.
[92] S. Cook,et al. Femoral Neck and Lumbar Spine Bone Mineral Densities in a Normal Population 3–20 Years of Age , 1991, Journal of pediatric orthopedics.
[93] K. Lyles,et al. Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention. , 1990, Journal of gerontology.
[94] D Osterweil,et al. The value of assessing falls in an elderly population. A randomized clinical trial. , 1990, Annals of internal medicine.
[95] R. Smith. Corticosteroids and osteoporosis. , 1990, Thorax.
[96] J. Montserrat,et al. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. , 1990, The American review of respiratory disease.
[97] L. Raisz,et al. Glucocorticoid-induced osteoporosis: pathogenesis and management. , 1990, Annals of internal medicine.
[98] Chang Lw,et al. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. , 1989 .
[99] E. Bergstralh,et al. Reversibility of steroid-induced osteoporosis. , 1988, The American journal of medicine.
[100] I. Reid,et al. TWO-YEAR FOLLOW-UP OF BIPHOSPHONATE (APD) TREATMENT IN STEROID OSTEOPOROSIS , 1988, The Lancet.
[101] A. Ehsani,et al. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. , 1988, Annals of internal medicine.
[102] I. Reid,et al. PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD) , 1988, The Lancet.
[103] J. Eisman,et al. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. , 1986, Annals of the rheumatic diseases.
[104] J. Dequeker,et al. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. , 1986, Annals of the rheumatic diseases.
[105] I. Reid,et al. Calcium supplements in the prevention of steroid-induced osteoporosis. , 1986, The American journal of clinical nutrition.
[106] B L Drinkwater,et al. Bone mineral density after resumption of menses in amenorrheic athletes. , 1986, JAMA.
[107] B. Chipps,et al. Reduction of serum testosterone levels during chronic glucocorticoid therapy. , 1986, Annals of internal medicine.
[108] M. Tinetti. Performance‐Oriented Assessment of Mobility Problems in Elderly Patients , 1986, Journal of the American Geriatrics Society.
[109] I. Reid,et al. Plasma testosterone concentrations in asthmatic men treated with glucocorticoids. , 1985, British medical journal.
[110] W. Murphy,et al. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. , 1985, Arthritis and rheumatism.
[111] W J Bremner,et al. Bone mineral content of amenorrheic and eumenorrheic athletes. , 1984, The New England journal of medicine.
[112] A. Adinoff,et al. Steroid-induced fractures and bone loss in patients with asthma. , 1983, The New England journal of medicine.
[113] E. Canalis. Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. , 1983, Endocrinology.
[114] Y. Ichikawa,et al. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. , 1983, Metabolism: clinical and experimental.
[115] W. Murphy,et al. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. , 1981, Arthritis and rheumatism.
[116] J. Adams,et al. Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients. , 1981, Metabolism: clinical and experimental.
[117] G. Hunder,et al. Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. , 1980, The Journal of clinical investigation.
[118] S. Teitelbaum,et al. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. , 1979, The Journal of clinical investigation.
[119] A. Hsueh,et al. Glucocorticoid inhibition of fsh-induced estrogen production in cultured rat granulosa cells , 1978, Steroids.
[120] B. Hahn,et al. Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy. , 1976, Seminars in arthritis and rheumatism.
[121] D. Fink,et al. SCREENING FOR BREAST CANCER , 1976, The Lancet.
[122] A. Weeks,et al. Letter: Ectopic pregnancy and the I.U.D. , 1975, Lancet.